Archive for category: Industry

ASIT biotech announces the grant of a European patent on the active ingredients used in the ASIT+™ allergy immunotherapy product candidates

ASIT biotech announces the grant of a European patent on the active ingredients used in the ASIT+™ allergy immunotherapy product candidates

/ October 19, 2017 9:00 am

Brussels, Belgium, October 17, 2017, 6:30 pm (CEST) – ASIT biotech (Euronext: ASIT – BE0974289218), a Belgian clinical-stage biopharmaceutical company focused on the research, development and future commercialization of breakthrough immunotherapy products for the treatment of allergies, announces the positive […]

BioArctic’s Patent for its Product Candidate Antibody BAN0805, for Parkinson’s Disease, is Now Granted in Europe

BioArctic’s Patent for its Product Candidate Antibody BAN0805, for Parkinson’s Disease, is Now Granted in Europe

/ October 13, 2017 8:53 am

Stockholm, Sweden, October 13, 2017 – BioArctic AB (publ) (Nasdaq Stockholm:BIOA B) today announced that the European Patent Office (EPO) has decided to grant a European patent (EP2539366) to BioArctic AB and the patent will be published on November 08, 2017. […]

CEL-SCI GRANTED EUROPEAN PATENT FOR MULTIKINE’S MECHANISM OF ACTION IN MAKING TUMORS ‘VISIBLE’ TO THE IMMUNE SYSTEM

CEL-SCI GRANTED EUROPEAN PATENT FOR MULTIKINE’S MECHANISM OF ACTION IN MAKING TUMORS ‘VISIBLE’ TO THE IMMUNE SYSTEM

/ October 13, 2017 8:45 am

CEL-SCI Corporation (NYSE American: CVM) announced today that the European Patent Office has issued a new patent to CEL-SCI for its lead investigational immunotherapy, Multikine* (Leukocyte Interleukin, Injection), which is currently in a pivotal Phase 3 trial for head and neck cancer. […]

New publication highlights importance of patents for Europe’s SMEs

New publication highlights importance of patents for Europe’s SMEs

/ September 29, 2017 8:27 am

Munich, 21 September 2017 - The EPO has published a set of 12 case studies which show how Europe’s small and medium-sized enterprises (SMEs) are successfully using patents for their business. The studies form a part of the EPO’s efforts to […]

Cantargia obtains patent approval in Europe for the antibody CAN04 in development for treatment of cancer

Cantargia obtains patent approval in Europe for the antibody CAN04 in development for treatment of cancer

/ September 14, 2017 10:00 am

Cantargia AB (”Cantargia”) today announced that the European Patent Office (“EPO”) has granted the company’s patent application on the product candidate CAN04. CAN04 is targeted against the molecule IL1RAP expressed in a large number of cancer diseases. The formal approval […]

RegeneRx Collaborators Receive Notice of ‘Intent to Grant’ EU Patent for the Treatment of Peripheral Neuropathy

RegeneRx Collaborators Receive Notice of ‘Intent to Grant’ EU Patent for the Treatment of Peripheral Neuropathy

/ August 22, 2017 8:32 am

RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) (“the Company” or “RegeneRx”), a clinical-stage drug development company focused on tissue protection, repair and regeneration, today announced that the European Patent Office (EPO) has issued an Intent to Grant notice related to Thymosin beta 4 […]

Suven Life secures Process Patents in Europe, Japan and New Zealand

Suven Life secures Process Patents in Europe, Japan and New Zealand

/ August 17, 2017 8:16 am

Suven Life Sciences Ltd (Suven) announces today that the grant of of one (1) process patent from Europe (3077375), one (1) process patent from Japan (6151453) and one (1) process patent from New Zealand (719671) corresponding to the New Chemical Entities (NCEs) which […]

European Patent Office to Grant Merck’s Patent Application for CRISPR Technology

European Patent Office to Grant Merck’s Patent Application for CRISPR Technology

/ August 10, 2017 9:50 am

Patent application covers integration of an external DNA sequence into the chromosome of eukaryotic cells using CRISPR Related patent application recently awarded in Australia; similar patents pending in other countries, favourable outcomes anticipated Darmstadt, Germany, August 3, 2017 — Merck, a leading […]

AzarGen Biotechnologies Granted European Patent for Plant-Made PRODUCTION OF RECOMBINANT HUMAN SURFACTANT PROTEIN-B

AzarGen Biotechnologies Granted European Patent for Plant-Made PRODUCTION OF RECOMBINANT HUMAN SURFACTANT PROTEIN-B

/ August 4, 2017 8:00 am

AzarGen Biotechnologies (Pty) Ltd (Stellenbosch, South Africa), announced that it has received grant status for the patent application: PRODUCTION OF HUMAN PULMONARY SURFACTANT PROTEIN-B IN PLANTS (EP3013963) from the European Patent Office. Exogenous pulmonary surfactant is routinely being used in surfactant […]

Cellectis Granted Patent for CRISPR Use in T-Cells

Cellectis Granted Patent for CRISPR Use in T-Cells

/ July 26, 2017 9:15 am

Cellectis (Alternext: ALCLS; Nasdaq: CLLS), a clinical-stage biopharmaceutical company focused on developing immunotherapies based on gene-edited CAR T-cells (UCART), today announced the grant by the European Patent Office of patent No. EP3004337 for the invention of using RNA-guided endonucleases, such […]